Evidence map›Paper›PMID 32940340›Full record

ArticleHistology and histopathology2020

Immunohistochemical determination of mTOR pathway molecules in ovaries and uterus in rat estrous cycle stages.

Gulcin Ekizceli, Sevinc Inan, Gulperi Oktem, Ece Onur, Kemal Ozbilgin

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Histology and histopathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. FOXO inBiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gulcin EkizceliDepartment of Histology and Embryology, Faculty of Medicine, Istanbul Health and Technology University, Istanbul, Turkey. ekizceli.g@gmail.com.
Sevinc InanDepartment of Histology and Embryology, Izmir Economy University, School of Medicine, Izmir, Turkey.
Gulperi OktemDepartment of Histology and Embryology, Ege University School of Medicine, Izmir, Turkey.
Ece OnurDepartment of Medical Biochemistry, Manisa Celal Bayar University, School of Medicine, Manisa, Turkey.
Kemal OzbilginDepartment of Histology and Embryology, Manisa Celal Bayar University, School of Medicine, Manisa, Turkey.
Ege University · TRManisa Celal Bayar University · TR

Funding

Celal Bayar University, Scientific Research Project Committee 2011/038
6 · The paper itself

Abstract

mTOR is a member of the PI3K/Akt/mTOR signaling pathway that participates in cell growth, proliferation, protein synthesis, transcription, angiogenesis, apoptosis and autophagy. mTOR and MAPK pahways are two important key signal pathways which are related to each other. We investigated the role of mTOR and other signaling molecules in rat ovaries and uteruses in stages of the estrous cycle. Young adult female rats were divided into four groups as proestrous, estrous, metestrous and diestrous according to vaginal smears. Immunohistochemical staining of mTORC1, IGF1, PI3K, pAKT1/2/3, ERK1 and pERK1/2 was performed and pAKT1/2/3 and ERK1 were also analyzed using western blotting on ovarian and uterine tissue samples. According to our results, PI3K/Akt/mTOR and ERK/pERK showed an increase in the rat ovulation period. When all the groups were evaluated the immunoreactivities for all of the antibodies were detected in the oocytes, granulosa and theca cells, corpus luteum and stroma of ovary and lamina propria, surface and glandular epithelium of uterus with the strongest observed with anti-ERK1 antibody and then with a decreasing trend with anti-mTORC1, anti-pAkt1/2/3, anti-IGF1, anti-PI3K and anti-pERK1/2 antibodies in the proestrus and estrus stages. Differently from other parts of the ovary, highest antibody expression in the corpus luteum was observed in the metestrous stage. Moreover, the existence of pAKT1/2/3 and ERK1 proteins was confirmed with the Western blotting technique. We suggest that mTOR and mTOR-related ERK signaling molecules may participate in the rat ovulation process.

Indexed as

AnimalsEstrous CycleExtracellular Signal-Regulated MAP KinasesFemaleImmunohistochemistryInsulin-Like Growth Factor IMechanistic Target of Rapamycin Complex 1OvaryPhosphatidylinositol 3-KinasePhosphorylationProto-Oncogene Proteins c-aktRats, WistarSignal TransductionTOR Serine-Threonine KinasesUterusExtracellular Signal-Regulated MAP Kinasesinsulin-like growth factor-1, ratInsulin-Like Growth Factor IMechanistic Target of Rapamycin Complex 1mTOR protein, ratPhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-aktTOR Serine-Threonine Kinases

Identifiers

PMID32940340
OpenAlexW3087329480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.